Selera Medical
DefunctYC W24San Francisco, US · Founded 2023 · 2 employees · 2 known investors
Find your way into Selera Medical
Sign up to see every warm intro you have to Selera Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Selera Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Selera Medical develops a minimally invasive implantable device that treats heart failure by removing excess fluid buildup, reducing hospitalizations and symptom recurrence through a single procedure.
Founders & leadership· Y Combinator alumni (W24)
Selera Medical was founded in 2023 by Stacie Arechavala and Kevin Bui.
SA

Stacie ArechavalaCofounder & CEOShe previously worked as an innovation fellow at Stanford Biodesign, held a chief of staff role at a healthtech startup, and served as an R&D engineer developing cardiovascular devices at Medtronic, with a master's degree in biomedical engineering and engineering management from Duke.
KB

Kevin BuiCo-Founder and CTOKevin Bui is co-founder and CTO of Selera Medical, which develops minimally invasive therapy for congestive heart failure. He previously served as an Innovation Fellow at Stanford's Byers Center for Biodesign and holds an undergraduate degree in bioengineering from Stanford and a PhD in bioengineering from the University of Pennsylvania, where his research focused on robotics, stroke rehabilitation, and cognitive neuroscience.
Investors · 2
Y Combinatorlisted by Y CombinatorSan Francisco · $500K
How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
Agrolimen Venturesreported
How we know: Y Combinator's founder network · Not right? Tell us
Related companies · 5
BodyportBodyport develops an FDA-cleared cardiac scale that non-invasively measures hemodynamic biomarkers through a patient's feet to detect early signs of worsening heart failure in a home setting. The company's platform pairs this hardware with a proprietary algorithm called the Congestion Index and a software system that integrates with electronic health records to enable remote patient monitoring and clinical decision support for heart failure management.
Obento HealthObento offers a health-focused experience, though specific details about its service model, customer type, and industry positioning are not clearly stated on the visible page content.
Relevium MedicalRelevium Medical is a biopharmaceutical company developing long-lasting treatments for chronic pain conditions, particularly osteoarthritis. The company focuses on therapeutic hydrogels and drug discovery for patients with debilitating pain.
BByBBy manufactures a device that converts breast milk into shelf-stable powder while preserving its immunological properties, serving neonatal intensive care units seeking to reduce preparation time and milk waste.
AuricleAuricle develops a neurostimulation implant designed to restore hearing for patients who do not benefit from hearing aids or existing solutions.
Companies working in the same space as Selera Medical.
Legal entities · 1
corporate structureSelera Medical, INC.
In the news
Frequently asked questions
- What does Selera Medical do?
- Selera Medical develops a minimally invasive implantable device that treats heart failure by removing excess fluid buildup, reducing hospitalizations and symptom recurrence through a single procedure.
- Who founded Selera Medical?
- Selera Medical was founded by Stacie Arechavala, Kevin Bui in 2023.
- Who are Selera Medical's investors?
- Selera Medical's investors include Y Combinator, Agrolimen Ventures.
- Where is Selera Medical headquartered?
- Selera Medical is headquartered in San Francisco, US.






